SCHEMBL2920213

SCHEMBL2920213

COc1cc(N2CCOCC2)ccc1Nc1nc(NCOc2ccc3c(c2)CCC(NCCO)CC3)ncc1Cl

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 5/20 0.60
ALK Q9UM73 11/20 0.59
INSR P06213 8/20 0.59
LRRK2 Q5S007 3/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
KCNH2 Q12809 1/20 0.54
ZAP70 P43403 3/20 0.52
IGF1R P08069 3/20 0.52
MAPK8 P45983 2/20 0.52
MAPK9 P45984 2/20 0.52
MAPK10 P53779 2/20 0.52
CDC7 O00311 1/20 0.51
PLK4 O00444 1/20 0.51
CHEK1 O14757 1/20 0.51
AURKA O14965 1/20 0.51
DCLK1 O15075 1/20 0.51
PDPK1 O15530 1/20 0.51
DAPK3 O43293 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL886472 0.85 ALK (0.65) EGFRALKINSRLRRK2CYP3A4
SCHEMBL884921 0.84 ALK (0.56) EGFRALKINSRLRRK2CYP3A4
SCHEMBL2920216 0.76 ALK (0.62) EGFRALKINSRLRRK2CYP3A4
SCHEMBL884776 0.75 ALK (0.73) EGFRALKINSRLRRK2CYP3A4
SCHEMBL21846988 0.75 EGFR (1.00) EGFRLRRK2
SCHEMBL2061740 0.73 ALK (0.91) EGFRALKINSRLRRK2CYP3A4
SCHEMBL4099957 0.73 ZAP70 (0.78) EGFRALKINSRLRRK2ZAP70
SCHEMBL2060832 0.72 ALK (0.82) EGFRALKINSRLRRK2ZAP70
SCHEMBL886129 0.72 ALK (0.85) EGFRALKINSRLRRK2CYP3A4
SCHEMBL26611806 0.72 EGFR (0.77) EGFRALKINSRLRRK2ZAP70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222647-A1 FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS Cephalon, Inc. (US) 2010-09-01 EP disclosed
WO-2008051547-A1 FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS CEPHALON, INC. (US) 2008-05-02 WO disclosed